Levine James E.

Average Profitability
3.13%
Insider Buys Quantity
7
Insider Buys Sum
$593,355.50
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Levine James E.

According to the SEC Form 4 filings, Levine James E., being in a position of

  1. Chief Financial Officer at Cardiff Oncology, Inc.,
    оver the last 12 months, has bought 7716 shares for $36,726, and sold 0 shares,
    over all time since 2021-09-10, has bought 67716 shares for $277,436, and sold 0 shares.

The largest purchase of all time was on 2020-11-10 and amounted to 100000 shares of Cidara Therapeutics, Inc. for $201,440.

Biography of Levine James E.

No biography is available at this moment.

2024-12-18PurchaseCardiff Oncology, Inc.
CRDF
Chief Financial Officer
2,400
0.0041%
$5.00$12,000-7.7%
2024-12-17PurchaseCardiff Oncology, Inc.
CRDF
Chief Financial Officer
2,752
0.0053%
$5.42$14,905-22.15%
2024-12-16PurchaseCardiff Oncology, Inc.
CRDF
Chief Financial Officer
2,564
0.0048%
$3.83$9,820+5.71%
2022-09-16PurchaseCardiff Oncology, Inc.
CRDF
Chief Financial Officer
30,000
0.0682%
$1.56$46,710+1.27%
2021-09-10PurchaseCardiff Oncology, Inc.
CRDF
Chief Financial Officer
30,000
0.0779%
$6.47$194,000-54.92%
2020-11-10PurchaseCidara Therapeutics, Inc.
CDTX
Chief Financial Officer
100,000
0.2343%
$2.01$201,440+6.28%
2019-09-24PurchaseCidara Therapeutics, Inc.
CDTX
Chief Financial Officer
60,000
0.1855%
$1.91$114,480+59.89%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.